Guido Guidi
Direktor/Vorstandsmitglied bei GENENTA SCIENCE S.P.A.
Vermögen: 188 067 $ am 30.04.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Duccio Neri | M | 61 | 28 Jahre | |
| Andrea Recordati | M | 52 | 26 Jahre | |
| Mario Zanone Poma | M | 85 |
Tethis SpA
 Tethis SpA BiotechnologyHealth Technology Tethis SpA engages in the provision of nanobiotechnology solutions. It develops devices for liquid biopsy, molecular diagnostic, and proteomic and microbiology. The company was founded by Emanuele Barborini, Simone Vinati, and Massimo Gatelli in 2004 and is headquartered in Milan Italy. | - |
| Pierluigi Paracchi | M | 50 | 10 Jahre | |
| Dario Neri | M | 61 | 28 Jahre | |
| Rajwinder Lehal | M | 48 |
Cellestia Biotech AG
 Cellestia Biotech AG Pharmaceuticals: MajorHealth Technology Cellestia Biotech AG manufactures anti-cancer drugs. Its pipeline product includes CB-103, a novel oral pan-NOTCH inhibitor for the treatment of NOTCH dependent leukemia, lymphoma, and solid tumors. The firm holds a worldwide exclusive license on the intellectual property rights for the development and commercialization of CB-103 and related series of close analogues. The company was founded by Freddy Radtke, Michael Bauer, Richard Peck, Dirk Weber and Rajwinder Lehal in 2014 and is headquartered in Basel, Switzerland. | 10 Jahre |
| Giovanni Neri | M | 55 | 28 Jahre | |
| Daniele Scarinci | M | - |
Tethis SpA
Tethis SpA BiotechnologyHealth Technology Tethis SpA engages in the provision of nanobiotechnology solutions. It develops devices for liquid biopsy, molecular diagnostic, and proteomic and microbiology. The company was founded by Emanuele Barborini, Simone Vinati, and Massimo Gatelli in 2004 and is headquartered in Milan Italy. | 6 Jahre |
| Joanna Le Couilliard | F | 60 | 5 Jahre | |
| Bernhard Gentner | M | - | 10 Jahre | |
| Luigi Naldini | M | - | 10 Jahre | |
| Maria Giovanna Calloni | F | 59 | 2 Jahre | |
| Roberto Tascione | M | - |
Zambon SpA
 Zambon SpA Pharmaceuticals: MajorHealth Technology Zambon SpA is engaged in manufacturing pharmaceutical products. It offers anauran, anaurette, asacol, codex, fluimucil, and giason. The company is headquartered in Bresso, Italy. | 8 Jahre |
| Giovanni Minora | M | - | 17 Jahre | |
| Marta Bavasso | F | 55 | 4 Jahre | |
| Richard Peck | M | 73 |
Cellestia Biotech AG
Cellestia Biotech AG Pharmaceuticals: MajorHealth Technology Cellestia Biotech AG manufactures anti-cancer drugs. Its pipeline product includes CB-103, a novel oral pan-NOTCH inhibitor for the treatment of NOTCH dependent leukemia, lymphoma, and solid tumors. The firm holds a worldwide exclusive license on the intellectual property rights for the development and commercialization of CB-103 and related series of close analogues. The company was founded by Freddy Radtke, Michael Bauer, Richard Peck, Dirk Weber and Rajwinder Lehal in 2014 and is headquartered in Basel, Switzerland. | 10 Jahre |
| Luigi la Corte | M | 54 | 5 Jahre | |
| Roberto Ferraresi | M | 48 | 5 Jahre | |
| Bastiaan van der Baan | M | 52 |
Tethis SpA
Tethis SpA BiotechnologyHealth Technology Tethis SpA engages in the provision of nanobiotechnology solutions. It develops devices for liquid biopsy, molecular diagnostic, and proteomic and microbiology. The company was founded by Emanuele Barborini, Simone Vinati, and Massimo Gatelli in 2004 and is headquartered in Milan Italy. | 3 Jahre |
| Federica de Medici | F | 51 | 4 Jahre | |
| Miro Venturi | M | - |
Tethis SpA
Tethis SpA BiotechnologyHealth Technology Tethis SpA engages in the provision of nanobiotechnology solutions. It develops devices for liquid biopsy, molecular diagnostic, and proteomic and microbiology. The company was founded by Emanuele Barborini, Simone Vinati, and Massimo Gatelli in 2004 and is headquartered in Milan Italy. | 3 Jahre |
| Silvia Signoretti | F | - | 1 Jahre | |
| Michaela Castelli | F | 53 | 10 Jahre | |
| Robert Koremans | M | 61 | 3 Jahre | |
| Roger Abravanel | M | 77 | 3 Jahre | |
| Anthony Marucci | M | 62 | 3 Jahre | |
| Piergiorgio Peluso | M | 56 | 4 Jahre | |
| Elisa Corghi | F | 51 | 2 Jahre | |
| Giampiero Mazza | M | 55 | 6 Jahre | |
| Gianni Marini | M | - |
Zambon SpA
Zambon SpA Pharmaceuticals: MajorHealth Technology Zambon SpA is engaged in manufacturing pharmaceutical products. It offers anauran, anaurette, asacol, codex, fluimucil, and giason. The company is headquartered in Bresso, Italy. | - |
| Raffaele Sabia | M | - | 7 Jahre | |
| Gabriele Finzi | M | - | 16 Jahre | |
| Dario Giusti | M | - |
Italfarmaco SpA
 Italfarmaco SpA Pharmaceuticals: MajorHealth Technology Italfarmaco SpA engages in the production and distribution of pharmaceutical and fine chemical products. It also provides research and development, scientific publishing, business development, and licensing services. The company was founded in 1938 and is headquartered in Milan, Italy. | - |
| Paolo Zambonardi | M | - |
Italfarmaco SpA
Italfarmaco SpA Pharmaceuticals: MajorHealth Technology Italfarmaco SpA engages in the production and distribution of pharmaceutical and fine chemical products. It also provides research and development, scientific publishing, business development, and licensing services. The company was founded in 1938 and is headquartered in Milan, Italy. | - |
| Laura Baldi | F | 52 | - | |
| Emanuele Puca | M | - | - | |
| Thibaud Eckenschwiller | M | - |
Zambon SpA
Zambon SpA Pharmaceuticals: MajorHealth Technology Zambon SpA is engaged in manufacturing pharmaceutical products. It offers anauran, anaurette, asacol, codex, fluimucil, and giason. The company is headquartered in Bresso, Italy. | 4 Jahre |
| Chiara Zambon | F | - |
Zambon SpA
Zambon SpA Pharmaceuticals: MajorHealth Technology Zambon SpA is engaged in manufacturing pharmaceutical products. It offers anauran, anaurette, asacol, codex, fluimucil, and giason. The company is headquartered in Bresso, Italy. | - |
| Karen Chu | M | - |
Cellestia Biotech AG
Cellestia Biotech AG Pharmaceuticals: MajorHealth Technology Cellestia Biotech AG manufactures anti-cancer drugs. Its pipeline product includes CB-103, a novel oral pan-NOTCH inhibitor for the treatment of NOTCH dependent leukemia, lymphoma, and solid tumors. The firm holds a worldwide exclusive license on the intellectual property rights for the development and commercialization of CB-103 and related series of close analogues. The company was founded by Freddy Radtke, Michael Bauer, Richard Peck, Dirk Weber and Rajwinder Lehal in 2014 and is headquartered in Basel, Switzerland. | - |
| Cathrin Petty | F | 51 | 6 Jahre | |
| Stefania Mazzoleni | M | 42 | 8 Jahre | |
| Maria Lamelas Godinez | F | - | 1 Jahre | |
| Tiziana Pollio | M | - | - | |
| Timothy J. Obara | M | - | 2 Jahre | |
| Alfredo Covelli | M | - | - | |
| Patrizia Sacchi | F | - | - | |
| Katia Lorizzo | M | - | - | |
| Bibianne Bon | F | - | 1 Jahre | |
| Carlo Russo | M | 71 | 3 Jahre | |
| Holger Neecke | M | - |
Tethis SpA
Tethis SpA BiotechnologyHealth Technology Tethis SpA engages in the provision of nanobiotechnology solutions. It develops devices for liquid biopsy, molecular diagnostic, and proteomic and microbiology. The company was founded by Emanuele Barborini, Simone Vinati, and Massimo Gatelli in 2004 and is headquartered in Milan Italy. | 2 Jahre |
| Roberto Gradnik | M | 68 |
Zambon SpA
Zambon SpA Pharmaceuticals: MajorHealth Technology Zambon SpA is engaged in manufacturing pharmaceutical products. It offers anauran, anaurette, asacol, codex, fluimucil, and giason. The company is headquartered in Bresso, Italy. | 11 Jahre |
| Ezio Maria Simonelli | M | 66 | - | |
| Giacomo di Nepi | M | 72 |
Zambon SpA
Zambon SpA Pharmaceuticals: MajorHealth Technology Zambon SpA is engaged in manufacturing pharmaceutical products. It offers anauran, anaurette, asacol, codex, fluimucil, and giason. The company is headquartered in Bresso, Italy. | - |
| Alvise Bonivento | M | - |
Tethis SpA
Tethis SpA BiotechnologyHealth Technology Tethis SpA engages in the provision of nanobiotechnology solutions. It develops devices for liquid biopsy, molecular diagnostic, and proteomic and microbiology. The company was founded by Emanuele Barborini, Simone Vinati, and Massimo Gatelli in 2004 and is headquartered in Milan Italy. | 8 Jahre |
| Francesco Granata | M | 73 |
Italfarmaco SpA
Italfarmaco SpA Pharmaceuticals: MajorHealth Technology Italfarmaco SpA engages in the production and distribution of pharmaceutical and fine chemical products. It also provides research and development, scientific publishing, business development, and licensing services. The company was founded in 1938 and is headquartered in Milan, Italy. | - |
| David Epstein | M | 62 |
Cellestia Biotech AG
Cellestia Biotech AG Pharmaceuticals: MajorHealth Technology Cellestia Biotech AG manufactures anti-cancer drugs. Its pipeline product includes CB-103, a novel oral pan-NOTCH inhibitor for the treatment of NOTCH dependent leukemia, lymphoma, and solid tumors. The firm holds a worldwide exclusive license on the intellectual property rights for the development and commercialization of CB-103 and related series of close analogues. The company was founded by Freddy Radtke, Michael Bauer, Richard Peck, Dirk Weber and Rajwinder Lehal in 2014 and is headquartered in Basel, Switzerland. | 2 Jahre |
| Massimo Tononi | M | 59 |
Zambon SpA
Zambon SpA Pharmaceuticals: MajorHealth Technology Zambon SpA is engaged in manufacturing pharmaceutical products. It offers anauran, anaurette, asacol, codex, fluimucil, and giason. The company is headquartered in Bresso, Italy. | - |
| Kim Stratton | F | 62 | 3 Jahre | |
| Robert Karsunky | M | - |
Cellestia Biotech AG
Cellestia Biotech AG Pharmaceuticals: MajorHealth Technology Cellestia Biotech AG manufactures anti-cancer drugs. Its pipeline product includes CB-103, a novel oral pan-NOTCH inhibitor for the treatment of NOTCH dependent leukemia, lymphoma, and solid tumors. The firm holds a worldwide exclusive license on the intellectual property rights for the development and commercialization of CB-103 and related series of close analogues. The company was founded by Freddy Radtke, Michael Bauer, Richard Peck, Dirk Weber and Rajwinder Lehal in 2014 and is headquartered in Basel, Switzerland. | - |
| Silvio Inderbitzin | M | 59 |
Cellestia Biotech AG
Cellestia Biotech AG Pharmaceuticals: MajorHealth Technology Cellestia Biotech AG manufactures anti-cancer drugs. Its pipeline product includes CB-103, a novel oral pan-NOTCH inhibitor for the treatment of NOTCH dependent leukemia, lymphoma, and solid tumors. The firm holds a worldwide exclusive license on the intellectual property rights for the development and commercialization of CB-103 and related series of close analogues. The company was founded by Freddy Radtke, Michael Bauer, Richard Peck, Dirk Weber and Rajwinder Lehal in 2014 and is headquartered in Basel, Switzerland. | 2 Jahre |
| Massimiliano Consonni | M | - |
Italfarmaco SpA
Italfarmaco SpA Pharmaceuticals: MajorHealth Technology Italfarmaco SpA engages in the production and distribution of pharmaceutical and fine chemical products. It also provides research and development, scientific publishing, business development, and licensing services. The company was founded in 1938 and is headquartered in Milan, Italy. | 5 Jahre |
| Giovanni Rizzo | M | - |
Tethis SpA
Tethis SpA BiotechnologyHealth Technology Tethis SpA engages in the provision of nanobiotechnology solutions. It develops devices for liquid biopsy, molecular diagnostic, and proteomic and microbiology. The company was founded by Emanuele Barborini, Simone Vinati, and Massimo Gatelli in 2004 and is headquartered in Milan Italy. | 4 Jahre |
| Elena Zambon | F | 59 |
Zambon SpA
Zambon SpA Pharmaceuticals: MajorHealth Technology Zambon SpA is engaged in manufacturing pharmaceutical products. It offers anauran, anaurette, asacol, codex, fluimucil, and giason. The company is headquartered in Bresso, Italy. | - |
| Witold Urban | M | - | 11 Jahre | |
| Giovanni Cagnoli | M | 64 |
Zambon SpA
Zambon SpA Pharmaceuticals: MajorHealth Technology Zambon SpA is engaged in manufacturing pharmaceutical products. It offers anauran, anaurette, asacol, codex, fluimucil, and giason. The company is headquartered in Bresso, Italy. | - |
| Giorgio de Palma | M | 49 | 4 Jahre | |
| Nathalie Francesca Dompé | F | 37 | - | |
| Giuseppe Gualazzini | M | 65 | 10 Jahre | |
| Margherita Zambon | F | 63 |
Zambon SpA
Zambon SpA Pharmaceuticals: MajorHealth Technology Zambon SpA is engaged in manufacturing pharmaceutical products. It offers anauran, anaurette, asacol, codex, fluimucil, and giason. The company is headquartered in Bresso, Italy. | - |
| Roberto Teruzzi | M | - | 9 Jahre | |
| Leopoldo Giampaolo Zambeletti | M | 55 | - | |
| Sergio Gianfranco Dompé | M | 68 | - | |
| Richard B. Slansky | M | 67 | 3 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Mark Sirgo | M | 70 | - | |
| Riccardo Rosati | M | - |
University of Milan
| 4 Jahre |
| Alfredo Altavilla | M | 60 | 2 Jahre | |
| Stephen P. Squinto | M | 67 | 1 Jahre | |
| Roberto Rettani | M | 71 |
University of Milan
| 4 Jahre |
| Paolo Boroli | M | 72 |
University of Milan
| 3 Jahre |
| Mario Colombo | M | 73 |
University of Milan
| 4 Jahre |
| François Roger | M | 52 |
Elanco Italia SpA
 Elanco Italia SpA Pharmaceuticals: MajorHealth Technology Elanco Italia SpA operates as a global health company. It provides products, services and knowledge to prevent and treat farmed and companion animal diseases in more than 90 countries. The company is headquartered in Sesto Fiorentino, Italy. | 2 Jahre |
| Giuseppe Carlo Vegas | M | 72 |
University of Milan
| 3 Jahre |
| Gian Giacomo Attolico Trivulzio | M | - |
University of Milan
| 4 Jahre |
| Marco Brughera | M | 70 |
University of Milan
| 3 Jahre |
| Ennio Bernasconi | M | - |
University of Milan
| 3 Jahre |
| Germano Carganico | M | 70 |
University of Milan
| 4 Jahre |
| Pietro Rossetto | M | 75 |
University of Milan
| 4 Jahre |
| Ravi Anand | M | 67 |
Elanco Italia SpA
Elanco Italia SpA Pharmaceuticals: MajorHealth Technology Elanco Italia SpA operates as a global health company. It provides products, services and knowledge to prevent and treat farmed and companion animal diseases in more than 90 countries. The company is headquartered in Sesto Fiorentino, Italy. | 4 Jahre |
| Piero del Soldato | M | - |
University of Milan
| 4 Jahre |
| Orio Bellezza | M | 65 |
University of Milan
| 4 Jahre |
| Riccardo Dalla-Favera | M | 72 |
University of Milan
| 3 Jahre |
| Gianni Camisa | M | - |
University of Milan
| 4 Jahre |
| Luigi Fumagalli | M | 64 |
University of Milan
| 3 Jahre |
| Luciano Bonacorsi | M | - |
University of Milan
| 3 Jahre |
| Michele Zefferino | M | 77 |
University of Milan
| 4 Jahre |
| Laura Iris Ferro | M | 72 |
University of Milan
| 3 Jahre |
| Roberto Giovanni Cera | M | 68 |
University of Milan
| 3 Jahre |
| Paolo Gavazzi | M | 77 |
University of Milan
| 9 Jahre |
| Daniele Raynaud | M | 65 |
University of Milan
| 4 Jahre |
| Giorgio Calesella | M | 69 |
University of Milan
| 3 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Italien | 94 | 94,00% |
| Schweiz | 6 | 6,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Guido Guidi
- Persönliches Netzwerk
